{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T20:01:36Z","timestamp":1791576096753,"version":"4.3.4"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,11]],"date-time":"2024-04-11T00:00:00Z","timestamp":1712793600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001632","name":"Ulster University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001632","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Peptides"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.peptides.2024.171218","type":"journal-article","created":{"date-parts":[[2024,4,14]],"date-time":"2024-04-14T01:45:51Z","timestamp":1713059151000},"page":"171218","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Positive interplay between FFAR4\/GPR120, DPP-IV inhibition and GLP-1 in beta cell proliferation and glucose homeostasis in obese high fat fed mice"],"prefix":"10.1016","volume":"177","author":[{"given":"A.I.","family":"Owolabi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.C.","family":"Corbett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.R.","family":"Flatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.M.","family":"McKillop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.peptides.2024.171218_bib1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12263-017-0554-6","article-title":"Effect of different concentrations of omega-3 fatty acids on stimulated THP-1 macrophages","volume":"12","author":"Allam-Ndoul","year":"2017","journal-title":"Genes Nutr."},{"issue":"7","key":"10.1016\/j.peptides.2024.171218_bib2","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1152\/ajpcell.00123.2015","article-title":"A novel anti-inflammatory role of GPR120 in intestinal epithelial cells","volume":"310","author":"Anbazhagan","year":"2016","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.peptides.2024.171218_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/JOE-13-0414","article-title":"Effects of glucagon-like peptide 1 on appetite and body weight: focus on the CNS","volume":"221","author":"Bloemendaal","year":"2014","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.peptides.2024.171218_bib4","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S1262-3636(08)73398-6","article-title":"GLP-1 receptor signaling: effects on pancreatic \u03b2-cell proliferation and survival","volume":"34","author":"Buteau","year":"2008","journal-title":"Diabetes Metab."},{"key":"10.1016\/j.peptides.2024.171218_bib5","doi-asserted-by":"crossref","first-page":"4312","DOI":"10.1021\/acs.jmedchem.0c01002","article-title":"GPR120\/FFAR4 Pharmacology: Focus on Agonists in Type 2 Diabetes Mellitus Drug Discovery","volume":"64","author":"Carullo","year":"2021","journal-title":"J. Med. Chem."},{"issue":"37","key":"10.1016\/j.peptides.2024.171218_bib6","article-title":"Beta cell dysfunction and insulin resistance","volume":"4","author":"Cerf","year":"2013","journal-title":"Front. Endocrinol."},{"issue":"11","key":"10.1016\/j.peptides.2024.171218_bib7","doi-asserted-by":"crossref","first-page":"452","DOI":"10.3390\/metabo10110452","article-title":"Beta Cell Physiological Dynamics and Dysfunctional Transitions in Response to Islet Inflammation in Obesity and Diabetes","volume":"10","author":"Cerf","year":"2020","journal-title":"Metabolites"},{"key":"10.1016\/j.peptides.2024.171218_bib8","article-title":"Metabolic Functions of G Protein-Coupled Receptors and \u03b2-Arrestin-Mediated Signaling Pathways in the Pathophysiology of Type 2 Diabetes and Obesity","volume":"12","author":"De Souza","year":"2021","journal-title":"Front. Endocrinol."},{"issue":"12","key":"10.1016\/j.peptides.2024.171218_bib9","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1093\/ibd\/izad161","article-title":"GPR120\/FFAR4: A Potential New Therapeutic Target for Inflammatory Bowel Disease","volume":"29","author":"Di Petrillo","year":"2023","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.peptides.2024.171218_bib10","doi-asserted-by":"crossref","first-page":"162","DOI":"10.3389\/fncel.2019.00162","article-title":"Fatty Acid Signaling Mechanisms in Neural Cells: Fatty Acid Receptors","volume":"13","author":"Falomir-Lockhart","year":"2019","journal-title":"Front. Cell. Neurosci."},{"issue":"5","key":"10.1016\/j.peptides.2024.171218_bib11","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/BF00252768","article-title":"Abnormal plasma glucose and insulin responses in heterozygous lean (ob\/+) mice","volume":"20","author":"Flatt","year":"1981","journal-title":"Diabetologia"},{"issue":"3","key":"10.1016\/j.peptides.2024.171218_bib12","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/s41574-020-00459-w","article-title":"Targeting lipid GPCRs to treat type 2 diabetes mellitus \u2013 progress and challenges","volume":"17","author":"Ghislain","year":"2021","journal-title":"Nat. Rev. Endocrinol."},{"issue":"1","key":"10.1016\/j.peptides.2024.171218_bib13","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nm1168","article-title":"Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120","volume":"11","author":"Hirasawa","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.peptides.2024.171218_bib14","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3389\/fendo.2014.00111","article-title":"Regulation of energy homeostasis via GPR120","volume":"5","author":"Ichimura","year":"2014","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.peptides.2024.171218_bib15","doi-asserted-by":"crossref","first-page":"236","DOI":"10.3389\/fphar.2014.00236","article-title":"Free fatty acid receptors as therapeutic targets for the treatment of diabetes","volume":"5","author":"Ichimura","year":"2014","journal-title":"Front. Pharmacol."},{"issue":"3","key":"10.1016\/j.peptides.2024.171218_bib16","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1210\/en.2014-1653","article-title":"Free Fatty Acid Receptor GPR120 Is Highly Expressed in Enteroendocrine K Cells of the Upper Small Intestine and Has a Critical Role in GIP Secretion After Fat Ingestion","volume":"156","author":"Iwasaki","year":"2015","journal-title":"Endocrinology"},{"issue":"10","key":"10.1016\/j.peptides.2024.171218_bib17","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1111\/1753-0407.13446","article-title":"Beta-cell function in type 2 diabetes (T2DM): Can it be preserved or enhanced?","volume":"15","author":"Kassem","year":"2023","journal-title":"J. Diabetes"},{"issue":"1","key":"10.1016\/j.peptides.2024.171218_bib18","doi-asserted-by":"crossref","DOI":"10.1210\/endocr\/bqac184","article-title":"Inside the \u03b2 Cell: Molecular Stress Response Pathways in Diabetes Pathogenesis","volume":"164","author":"Kulkarni","year":"2023","journal-title":"Endocrinology"},{"key":"10.1016\/j.peptides.2024.171218_bib19","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1210\/endocr\/bqab145","article-title":"Does FFAR4 Agonism have Therapeutic Potential in Cardiometabolic Disease?","volume":"162","author":"Lay","year":"2021","journal-title":"Endocrinology"},{"issue":"13","key":"10.1016\/j.peptides.2024.171218_bib20","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.4239\/wjd.v6.i13.1246","article-title":"Diabetes and cardiovascular disease: Epidemiology, biological mechanisms, treatment recommendations and future research","volume":"6","author":"Leon","year":"2015","journal-title":"World J. Diabetes"},{"key":"10.1016\/j.peptides.2024.171218_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.115398","article-title":"Antidiabetic actions of GPR55 agonist Abn-CBD and sitagliptin in obese-diabetic high fat fed mice","volume":"208","author":"McCloskey","year":"2023","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.peptides.2024.171218_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.121475","article-title":"Incretins play an important role in FFA4\/GPR120 regulation of glucose metabolism by GW-9508","volume":"318","author":"McKillop","year":"2023","journal-title":"Life Sci."},{"key":"10.1016\/j.peptides.2024.171218_bib23","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1111\/bph.12356","article-title":"Evaluation of the insulin releasing and antihyperglycaemic activities of GPR55 lipid agonists using clonal beta-cells, isolated pancreatic islets and mice","volume":"170","author":"McKillop","year":"2013","journal-title":"Br. J. Pharmacol."},{"issue":"12","key":"10.1016\/j.peptides.2024.171218_bib24","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1007\/s00125-016-4108-z","article-title":"Metabolic effects of orals administered small-molecule agonists of GPR55 and GPR119 in multiple low-dose streptozotocin-induced diabetic and incretin-receptor-knockout mice.","volume":"59","author":"McKillop","year":"2016","journal-title":"Diabetologia"},{"issue":"9","key":"10.1016\/j.peptides.2024.171218_bib25","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.tips.2017.06.006","article-title":"FFA4\/GPR120: Pharmacology and Therapeutic Opportunities","volume":"38","author":"Milligan","year":"2017","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.peptides.2024.171218_bib26","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/1476-511X-12-101","article-title":"Omega-3 and omega-6 PUFAs induce the same GPR120-mediated signalling events, but with different kinetics and intensity in Caco-2 cells","volume":"12","author":"Mobraten","year":"2013","journal-title":"Lipids Health Dis."},{"issue":"10","key":"10.1016\/j.peptides.2024.171218_bib27","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1111\/dom.14462","article-title":"Weight-reducing, lipid-lowering and antidiabetic activities of a novel arginine vasopressin analogue acting at the V1a and V1b receptors in high-fat-fed mice","volume":"23","author":"Mohan","year":"2021","journal-title":"Diabetes, Obes. Metab."},{"issue":"11","key":"10.1016\/j.peptides.2024.171218_bib28","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1111\/dom.12330","article-title":"Evaluation of the insulin-releasing and glucose-lowering effects of GPR120 activation in pancreatic \u03b2-cells","volume":"16","author":"Moran","year":"2014","journal-title":"Diabetes, Obes. Metab."},{"key":"10.1016\/j.peptides.2024.171218_bib29","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s00592-015-0826-9","article-title":"G protein-coupled receptors: signalling and regulation by lipid agonists for improved glucose homeostasis","volume":"53","author":"Moran","year":"2016","journal-title":"Acta Diabetol."},{"issue":"5","key":"10.1016\/j.peptides.2024.171218_bib30","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.cell.2010.07.041","article-title":"GPR120 is an Omega-3 Fatty Acid Receptor Mediating Potent Anti-Inflammatory and Insulin Sensitizing Effects","volume":"142","author":"Oh","year":"2010","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.peptides.2024.171218_bib31","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/nm.3614","article-title":"A Gpr120 Selective Agonist Improves Insulin Resistance and Chronic Inflammation","volume":"20","author":"Oh","year":"2014","journal-title":"Nat. Med."},{"issue":"6","key":"10.1016\/j.peptides.2024.171218_bib32","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.cmet.2020.04.020","article-title":"Positive Reinforcing Mechanisms between GPR120 and PPAR\u03b3 Modulate Insulin Sensitivity","volume":"31","author":"Paschoal","year":"2020","journal-title":"Cell Metab."},{"issue":"2","key":"10.1016\/j.peptides.2024.171218_bib33","doi-asserted-by":"crossref","first-page":"88227","DOI":"10.1371\/journal.pone.0088227","article-title":"Expression of the Fatty Acid Receptor GPR120 in the Gut of Diet-Induced-Obese Rats and Its Role in GLP-1 Secretion","volume":"9","author":"Paulsen","year":"2014","journal-title":"PLoS ONE"},{"issue":"13","key":"10.1016\/j.peptides.2024.171218_bib34","doi-asserted-by":"crossref","first-page":"5073","DOI":"10.1021\/jf0702693","article-title":"Anti-inflammatory effect of alpha-linolenic acid and its mode of action through the inhibition of nitric oxide production and inducible nitric oxide synthase gene expression via NF-kappaB and mitogen-activated protein kinase pathways","volume":"55","author":"Ren","year":"2007","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.peptides.2024.171218_bib35","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12575-019-0116-y","article-title":"Exploring G Protein-Coupled Receptor Signaling in Primary Pancreatic Islets","volume":"22","author":"R\u00f6the","year":"2020","journal-title":"Biol. Proced. Online"},{"key":"10.1016\/j.peptides.2024.171218_bib36","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1007\/s00018-017-2492-2","article-title":"GPR120: a critical role in adipogenesis, inflammation, and energy metabolism in adipose tissue","volume":"74","author":"Song","year":"2017","journal-title":"Cell. Mol. Life Sci."},{"issue":"9","key":"10.1016\/j.peptides.2024.171218_bib37","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.tips.2011.04.004","article-title":"Targeting GPR120 and other fatty acid-sensing GPCRs ameliorates insulin resistance and inflammatory diseases","volume":"32","author":"Talukdar","year":"2011","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.peptides.2024.171218_bib38","series-title":"Pharmacological modulation of pancreatic beta-to-alpha cell transdifferentiation in diabetes","author":"Tanday","year":"2019"},{"issue":"17-18","key":"10.1016\/j.peptides.2024.171218_bib39","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1101\/gad.348261.121","article-title":"Discovery of ciliary G protein-coupled receptors regulating pancreatic islet insulin and glucagon secretion","volume":"35","author":"Wu","year":"2021","journal-title":"Genes Dev."},{"key":"10.1016\/j.peptides.2024.171218_bib40","first-page":"1013","article-title":"Potential roles of GPR120 and its agonists in the management of diabetes","volume":"8","author":"Zhang","year":"2014","journal-title":"Drug Des., Dev. Ther."}],"container-title":["Peptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978124000718?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978124000718?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,31]],"date-time":"2024-05-31T00:35:46Z","timestamp":1717115746000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196978124000718"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":40,"alternative-id":["S0196978124000718"],"URL":"https:\/\/doi.org\/10.1016\/j.peptides.2024.171218","relation":{},"ISSN":["0196-9781"],"issn-type":[{"value":"0196-9781","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Positive interplay between FFAR4\/GPR120, DPP-IV inhibition and GLP-1 in beta cell proliferation and glucose homeostasis in obese high fat fed mice","name":"articletitle","label":"Article Title"},{"value":"Peptides","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.peptides.2024.171218","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"171218"}}